KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Receivables (2016 - 2025)

Johnson & Johnson (JNJ) has disclosed Receivables for 17 consecutive years, with $17.2 billion as the latest value for Q4 2025.

  • Quarterly Receivables rose 15.74% to $17.2 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $17.2 billion through Dec 2025, up 15.74% year-over-year, with the annual reading at $17.2 billion for FY2025, 15.74% up from the prior year.
  • Receivables hit $17.2 billion in Q4 2025 for Johnson & Johnson, down from $17.6 billion in the prior quarter.
  • In the past five years, Receivables ranged from a high of $17.8 billion in Q2 2025 to a low of $13.6 billion in Q1 2021.
  • Historically, Receivables has averaged $15.6 billion across 5 years, with a median of $15.6 billion in 2022.
  • Biggest five-year swings in Receivables: fell 8.59% in 2024 and later grew 15.74% in 2025.
  • Year by year, Receivables stood at $14.9 billion in 2021, then rose by 6.57% to $15.9 billion in 2022, then dropped by 6.4% to $14.9 billion in 2023, then decreased by 0.21% to $14.8 billion in 2024, then rose by 15.74% to $17.2 billion in 2025.
  • Business Quant data shows Receivables for JNJ at $17.2 billion in Q4 2025, $17.6 billion in Q3 2025, and $17.8 billion in Q2 2025.